United Therapeutics reported $311.4M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 59.48M 9.66M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Amarin AMRN:US $ 370.44M 44.67M
Ardelyx ARDX:US $ 57.78M 16M
Arena Pharmaceuticals ARNA:US $ 64.84M 17.33M
Baxter International BAX:US $ 3344M 157M
Bayer BAYN:GR € 27926M 1006M
Biogen BIIB:US $ 3347.2M 181.4M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Emergent Biosolutions EBS:US $ 377.8M 7.6M
Esperion Therapeutics ESPR:US $ 82.64M 15.25M
Gilead Sciences GILD:US $ 10214M 509M
GlaxoSmithKline GSK:LN 21387M 1112M
Halozyme Therapeutics HALO:US $ 114.25M 6.83M
Insmed INSM:US $ 99.66M 18.26M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Intra Cellular Therapies ITCI:US $ 50.42M 10.72M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
Moderna Inc MRNA:US 8.84B 399M
Omeros OMER:US $ 47.7M 4.26M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Teva Pharmaceutical TEVA:IT 12.69B 602M
United Therapeutics UTHR:US $ 311.4M 9M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M